Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Prevalence of Multiple Sclerosis (MS) has increased over the last decades, primarily among women of childbearing age. Several algorithms for identifying MS have been described in the literature, providing heterogeneous prevalence estimates. We compared five algorithms to identify MS in women of childbearing age and estimated MS prevalence by time period and age-group. The study population included women aged 15 to 49 years-old between 2005 and 2019, from three data sources including all women (from Italy, Norway, and Wales), and three including pregnant women only (from France, Finland, and Spain; data collected around pregnancy). Five algorithms were tested: MS1 to MS3 combined MS diagnoses and MS-medicine prescriptions/dispensations, requiring 1, 2, or 3 occurrences, respectively; MS4 and MS5 used only MS diagnoses, requiring at least 2 occurrences (MS4 allowed just 1 if diagnosis was from inpatient care). In 2015-2019, MS prevalence based on MS1 ranged from 109 to 359 per 100,000 women: 109 in France, 121 in Spain, 195 in Wales, 232 in Finland, 264 in Italy, and 359 in Norway. More restrictive algorithms led to greater disparity, with MS3 ranging from 53 in Spain to 325 in Norway, and MS5 from 21 in France to 345 in Norway. All algorithms showed expected prevalence trends by time and age among women of childbearing age, though lower than in the literature. Overall, MS1 provided prevalence estimates most closely aligned with existing literature. This study offers key insights into choosing algorithms for identifying MS in women of childbearing age and in pregnant women.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12374901PMC
http://dx.doi.org/10.1007/s10654-025-01264-3DOI Listing

Publication Analysis

Top Keywords

women childbearing
20
childbearing age
20
women
10
multiple sclerosis
8
algorithms identifying
8
prevalence estimates
8
pregnant women
8
requiring occurrences
8
occurrences ms4
8
age
6

Similar Publications

Objective: We evaluated real-world treatment patterns and unmet needs associated with migraine preventive medications in Japan following the introduction of calcitonin gene-related peptide monoclonal antibodies (CGRP mAbs), focusing on persistence, switching, and adherence rates.

Methods: This retrospective cohort study analyzed JMDC (previously Japan Medical Data Center) claims data (index date: April 2021 to January 2024) for treatment-naïve patients who initiated oral migraine preventive medications (OMPMs;  = 12,750) and patients initiating CGRP mAbs ( = 3,280). Persistence was defined as continuous therapy without a 60-day or longer gap.

View Article and Find Full Text PDF

Medically-assisted reproduction in Italy, 2021 data from the Italian MAR Registry.

Minerva Obstet Gynecol

September 2025

Italian Medically Assisted Reproduction Register, National Centre for Diseases Prevention and Health Promotion, Italian, National Health Institute, Rome, Italy -

Background: The Italian Medically Assisted Reproduction Registry (ItMARR) was established by a Decree of the Minister of Health issued on October 7, 2005. ItMARR has a crucial role in clearly and publicly disseminating epidemiological information on MAR activities and outcomes.

Methods: ItMARR data are collected in aggregate form and their submission is mandatory as stipulated by Law 40/2004.

View Article and Find Full Text PDF

Purpose: This study aims to systematically quantify the global burden of osteoarthritis (OA) in women of childbearing age (WCBA) and analyze its temporal trends and regional disparities.

Methods: This study utilized the Global Burden of Disease 2021 data to assess the incidence and years lived with disability (YLDs) spanning from 1990 to 2021. The Bayesian age-period-cohort (BAPC) model was adopted to forecast trends up to 2045.

View Article and Find Full Text PDF

Aims: Intimate Partner Violence (IPV) presents a significant global public health issue, particularly affecting women of childbearing age (WBCA). The COVID-19 pandemic has exacerbated the IPV globally. This study aimed to assess the global burden and health inequalities attributable to IPV among WBCA from 1990 to 2021.

View Article and Find Full Text PDF

Purpose: This study aims to explore global, regional, and national trends in the prevalence of depression and disability-adjusted life years (DALYs) among women of childbearing age from 1990 to 2021, as well as to project future trends from 2022 to 2040.

Methods: This research analyzes the prevalence of depression and Disability-Adjusted Life Years (DALYs) among Women of Childbearing Age (WCBA) using data from the Global Burden of Disease (GBD) database, covering the period from 1990 to 2021. We evaluate trends in the burden of depression in WCBA through estimated annual percentage change (EAPC) and percentage change, as well as annual percentage change (APC) and average annual percentage change (AAPC) derived from Joinpoint regression analyses.

View Article and Find Full Text PDF